Kaggle and Booz Allen Hamilton will convene medical communities and data scientists for a challenge to use artificial intelligence in efforts to further develop lung cancer screening technology.
The companies said Thursday the 90-day Data Science Bowl competition will look to boost current technologies for the early detection of lung cancer and potentially reduce lung cancer fatalities by as much as 20 percent.
Participants will utilize a data set of National Cancer Institute-provided lung scans from the Cancer Imaging Program to develop artificial intelligence algorithms that determine when lesions in the lungs are cancerous.
“Artificial Intelligence and human ingenuity can be powerful in the fight against cancer,” said Josh Sullivan, a Booz Allen senior vice president.
Kaggle CEO Anthony Goldbloom said the competition looks to reduce false positive rate of low-dose CT scans as well as address inaccuracy in lung cancer diagnoses to support early detection of cancer.